FTY720 blocks allograft rejection by homing of lymphocytes in vivo.
Yuzawa
K
K
Division of Immunology. Department of Surgery, The University of Texas Medical School at Houston, Houston, Texas, USA.
Stephkowski
S M
SM
Wang
M
M
Kahan
B D
BD
D000818:Animals; D000068876:Fingolimod Hydrochloride; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011409:Propylene Glycols / Q000627:therapeutic use*; D051381:Rats; D011915:Rats, Inbred BUF; D011920:Rats, Inbred WF; D013110:Sphingosine / Q000031:analogs & derivatives; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology*; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine